CBD Businesses are misleading consumers, It is vital that traceability is open to the public! 

CBD supplements presently outsell vitamin C supplements and can be located on almost every high street across the country. Despite a new report conducted by the Centre for Medicinal Cannabis which tested over 30 oil products available in the UK it has identified some worrying concerns for retailers of CBD products.  

The first main third-party testing operation has been undertaken regarding CBD products in the United Kingdom In total, 30 oil products available in the UK (both on and offline) were selected for the blind testing exercise using
PhytoVista - a reputable UK-based laboratory - the same lab that UK CBD Oils use.

The investigation was designed to verify the range of quality of those CBD products sold today and to determine where the areas of concern might Be. Those areas were defined as health and safety; consumer rights; and criminal law

The results are highly revealing and provide a good overview of the true nature of the CBD products Being sold in the UK. They show a wide range in terms of quality, and some concerning the poor practice In a minority of cases. The best products are very high quality and are good options for today’s consumers, but a larger group of products present Issues in one area or another.


The most significant issues related to the accuracy of labelling; the presence of controlled substances and some contaminants; and in one example from a high street pharmacy, the complete absence of any Cannabinoids. 

Highlights:
Only 11/29 (38%) of the products were within 10% of the advertised CBD content and 11/29 products (38%) actually had less than 50% of the advertised CBD content. One product had 0% CBD.

Almost half (45%) of the chosen products had weighable levels of THC (content 0.04%) or CBN (mean content 0.01%) and are therefore Technically prohibited inside the UK.


1 sample had no cannabinoid content - and this was a High Street pharmacy product (30ml) Retailing for £90.

1 product had 3.8% ethanol (3.4% qualifies as an alcoholic beverage)

Dichloromethane was detectable in 7 products (3.8-13.1ppm) and cyclohexane was found in one Product (27.9ppm). However, these percentages  of solvents and heavy metals are still below the permitted daily dose levels in pharmaceutical products, although above food limit safety levels


The exercise also exposed regulatory gaps - with no rules that set basic standards for important supply chain activities like testing of cannabinoid products, so those laboratories (in the UK or elsewhere) that conduct these examinations all use different processes and testing methodologies and they may not be to a standard that is reliable or would satisfy UK authorities


Report by the Centre for Medicinal Cannabis. CBD in the UK.

Download the full report here